Literature DB >> 30763602

The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.

Felix Nagel1, David Santer2, Stefan Stojkovic3, Christoph Kaun3, Anne-Kristin Schaefer4, Martin Krššák5, Dietmar Abraham6, Péter Bencsik7, Péter Ferdinandy8, Eva Kenyeres9, Tamara Szabados9, Johann Wojta10, Karola Trescher1, Attila Kiss4, Bruno K Podesser11.   

Abstract

The aim of this study was to describe the potential associations of the expression of matricellular components in adverse post-infarction remodeling of the geriatric heart. In male geriatric (OM, age: 18 months) and young (YM, age: 11 weeks) OF1 mice myocardial infarction (MI) was induced by permanent ligation of the left anterior descending coronary artery. Cardiac function was evaluated by MRI. Plasma and myocardial tissue samples were collected 3d, 7d, and 32d post-MI. Age and MI were associated with impaired cardiac function accompanied by left-ventricular (LV) dilatation. mRNA expression of MMP-2 (7d: p < 0.05), TIMP-1 (7d: p < 0.05), TIMP-2 (7d: p < 0.05), Collagen-1 (3d and 7d: p < 0.05) and Collagen-3 (7d: p < 0.05) in LV non-infarcted myocardium was significantly higher in YM than in OM after MI. MMP-9 activity in plasma was increased in OM after MI (3d: p < 0.01). Tenascin-C protein levels assessed by ELISA were decreased in OM as compared to YM after MI in plasma (3d: p < 0.001, 7d: p < 0.05) and LV non-infarcted myocardium (7d: p < 0.01). Dysregulation in ECM components in non-infarcted LV might be associated and contribute to adverse LV remodeling and impaired cardiac function. Thus, targeting ECM might be a potential therapeutic approach to enhance cardiac function in geriatric patients following MI.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Extracellular matrix remodeling; MMPs; Myocardial infarction; TIMPs; Tenascin-C

Mesh:

Substances:

Year:  2019        PMID: 30763602     DOI: 10.1016/j.exger.2019.02.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  2 in total

1.  Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice.

Authors:  David Santer; Felix Nagel; Inês Fonseca Gonçalves; Christoph Kaun; Johann Wojta; Miklós Fagyas; Martin Krššák; Ágnes Balogh; Zoltán Papp; Attila Tóth; Viktor Bánhegyi; Karola Trescher; Attila Kiss; Bruno K Podesser
Journal:  ESC Heart Fail       Date:  2020-07-08

Review 2.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.